Dongwon Group Looking To Expand In Pharmaceutical Sector
Korean Dongwon Group is planning to enter the biomedical and pharmaceutical sectors using tuna byproducts as part of its future strategy. The conglomerate wants to develop health functional foods and supplements, but plans are still in a nascent stage. The...
Subscribe to Continue Reading
Become a member and unlock unlimited access to daily tuna news, market data, and trade statistics.
Already a member? Sign In
Subscriptions renew automatically. Taxes added at checkout. You may cancel your subscription at any time.
- Unlimited access to in-depth articles, daily newsletters, and breaking tuna news alerts
- Full access to tuna prices per production hub, plus import & export trade statistics
- Historical data archive dating back to 1998